Hepatitis B virus vaccine failure resulting in chronic hepatitis B infection

Journal of Clinical Virology

Volumn 52, Issue 2, 2011, Pages 151-154

  O'Halloran, J A ^a   De Gascun, C F ^b   Dunford, L ^b   Carr, M J ^b   Connell, J ^b   Howard, R ^a   Hall, W W ^b   Lambert, J S ^a,b  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Genotype F; HBV; Hepatitis B infection; MSM; Vaccine; Vaccine failure

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS A HEPATITIS B VACCINE; HEPATITIS B SURFACE ANTIBODY; RECOMBINANT HEPATITIS B VACCINE; VIRUS DNA;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; BIOCHEMISTRY; CASE REPORT; CHRONIC HEPATITIS; ENZYME BLOOD LEVEL; FATIGUE; HEPADNAVIRUS INFECTION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOASSAY; MALE; MYALGIA; PHYLOGENY; PRIORITY JOURNAL; SEROLOGY; TREPONEMA PALLIDUM; TREPONEMATOSIS; VACCINE FAILURE;

ADULT; GENOME, VIRAL; GENOTYPE; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; MALE; PHYLOGENY;

EID: 80052731738     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2011.06.020     Document Type: Article

References (23)

1. Gunther S., Sommer G., Von Breunig F., Iwanska A., Kalinina T., Sterneck M., et al. Amplification of full-length hepatitis B virus genomes from samples from patients with low levels of viremia: frequency and functional consequences of PCR-introduced mutations. J Clin Microbiol 1998, 36:531-538.
2. Piñeiro Y., Leone F.G., Pezzano S.C., Torres C., Rodríguez C.E., Eugenia Garay M., et al. virus genetic diversity in Argentina: dissimilar genotype distribution in two different geographical regions; description of hepatitis B surface antigen variants. J Clin Virol 2008, 42:381-388.
3. Trinks J., Cuestas M.L., Tanaka Y., Mathet V.L., Minassian M.L., Rivero C.W., et al. Two simultaneous hepatitis B virus epidemics among injecting drug users and men who have sex with men in Buenos Aires, Argentina: characterization of the first D/A recombinant from the American continent. J Viral Hepat 2008, 15(11):827-838.
4. Kann M. Structural and molecular virology of hepatitis B virus. Hepatitis B virus. Human virus guides 1 2008, International Medical Press, p. 2.1-2.14.
5. Chan H.L., Hussain M., Lok A.S. Different hepatitis B virus genotypes are associated with different mutations in the core promoter and precore regions during hepatitis B e antigen seroconversion. Hepatology 1999, 29(3):976-984.
6. American Academy of Paediatrics Hepatitis B. Red book: 2006 report of the committee on infectious diseases 2006, 350. American Academy of Paediatrics, Elk Grove Village, IL. 27th ed. L.K. Pickering, C.J. Baker, S.S. Long, J.A. McMillan (Eds.).
7. United Kingdom Department of Health. Hepatitis B. In: Salisbury D, Ramsay M, Noakes K, editors. Green book: 2006 immunisation against infectious disease.
8. National Immunisation Advisory Committee of the Royal College of Physicians of Ireland Hepatitis B. Blue book: immunisation guidelines for Ireland 2008.
9. European Consensus Group on Hepatitis B Immunity Are booster immunisations needed for lifelong hepatitis B immunity?. Lancet 2000, 355(9203):561-565.
10. Poovorawan Y., Theamboonlers C.V., Bock A., Leyssen H.L., Jacquet M.J.M. Persistence of antibodies and immune memory to hepatitis B vaccine 20 years after infant vaccination in Thailand. Vaccine 2010, 28(3):730-736.
11. Poorolajal J., Majdzadeh M.M., Nasseri-Moghaddam R., Haghdoost S., Fotouhi A.A. Long term protection provided by hepatitis B vaccine and need for booster dose: a meta-analysis. Vaccine 2010, 28(3):623-631.
12. McMahon B.J., Bruden D.C., Zanis D., Peters C., Hurlburt H., Bulkow D., et al. Antibody levels and protection after hepatitis B vaccine results of a 22-year follow-up study and response to a booster dose. J Infect Dis 2009, 200(9):1390-1396.
13. Van Damme P.V.H.K. A review of the long-term protection after hepatitis A and B vaccination. Travel Med Infect Dis 2007, 5(2):79-84.
14. Fisman D.N., Leder A.D.K. The effect of age on immunologic response to recombinant hepatitis B vaccine: a meta analysis. Clin Infect Dis 2002, 35:1368-1375.
15. Jafarzadeh A., Shokri Z.S.F. Low dose revaccination induces robust protective anti-HBs antibody response in the majority of healthy non-responder neonates. Vaccine 2008, 26(2):269-276.
16. Jacques P., Desombere M.G., Dewijngaert I., Leroux-Roels J., Wettendorff G., Thoelen M.S. The immunogenicity and reactogenicity profile of a candidate hepatitis B vaccine in an adult vaccine non-responder population. Vaccine 2002, 20(31-32):3644-3649.
17. Boot H.J., Van der Waail L.A., Schirm J., Kallenberg C.G.M., Van Steenbergen J., Wolters B. Acute hepatitis B in a healthcare worker: a case report of genuine vaccination failure. J Hepatol 2009, 50(2):426-431.
18. Tacke F., Amini-Bavil-Olyaee S., Heim A., Luedde T., Manns M.P., Trautwein C. Acute hepatitis B infection by genotype F despite successful vaccination in an immune-competent German patient. J Clin Virol 2007, 38:353-357.
19. West D.J. Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination. Vaccine 1996, 14(11):1019-1027.
20. Devesa M., Pujol F.H. Hepatitis B virus genetic diversity in Latin America. Virus Res 2007, 127:177-184.
21. Laoi B.N., Crowley B. Molecular characterization of hepatitis B virus (HBV) isolates, including identification of a novel recombinant, in patients with acute HBV infection attending an Irish hospital. J Med Virol 2008, 80:1554-1564.
22. Pezzano S.C., Torres C., Fainboim H.A., Bouzas M.B., Schroder T., Giuliano S.F., et al. Hepatitis B virus in Buenos Aires Argentina: genotypes, virological characteristics and clinical outcomes. Clin Microbiol Infect 2011, 17(2):223-231.
23. Liao S.S., Li R.C., Li H., Yang J.Y., Zeng X.J., Gong J., et al. Long-term efficacy of plasma-derived hepatitis B vaccine among Chinese children: a 12-year follow-up study. World J Gastroenterol 1999, 5(2):165-166.